TSG Therapeutics

About:

TSG Therapeutics is a preclinical-stage biopharmaceutical firm dedicated to the abolition of viral infectious illness.

Website: http://www.tsg-therapeutics.com/

Top Investors: SparkLabs Accelerator, Daehan New Pharm

Description:

TSG Therapeutics is a preclinical-stage biopharmaceutical company on a mission to eliminate viral infectious disease. TSG has designed a novel class of broad-spectrum antiviral drugs that are adaptable, scalable, and therapeutically effective against a wide range of emerging and re-emerging viruses. By utilizing disruptive approaches across engineering and medicine, we have developed a proven platform for developing drug candidates with potent antiviral activity against diverse classes of viruses. Whereas conventional approaches are based on a narrow “one bug, one drug” concept, our strategy is driven by a “one drug, many bugs” vision that will lead to clinical solutions for a wide range of viral infections and improve billions of lives around the world. TSG Therapeutics was established on April 1, 2016 by Will W. Park in Singapore, Central Region.